Pricing Log in Create free account

Arcturus Therapeutics Holdings Inc. (ARCT) vs Clinuvel Pharmaceuticals Ltd. - Sponsored ADR (CUVL)

Arcturus Therapeutics Holdings Inc. and Clinuvel Pharmaceuticals Ltd. - Sponsored ADR are both Biotechnology companies. Arcturus Therapeutics Holdings Inc. is the larger, with a market value of $298.3M against $257.5M — 1.2× the size.

Valuation

Metric ARCT CUVL Biotechnology median
P/E n/m — 10.60
P/S 9.65 — 9.40
P/B 1.74 — 2.13
Price to free cash flow n/m — 25.18
EV/EBITDA n/m — 0.66
EV/Sales 6.07 — 9.02
Earnings yield (29.76%) — (32.88%)
Free cash flow yield (21.20%) — (23.13%)

Profitability

Metric ARCT CUVL Biotechnology median
Gross margin 100.00% — 68.51%
Operating margin (311.22%) — 0.00%
Net margin (285.91%) — 0.00%
Free cash flow margin (204.48%) — 0.00%
Return on equity (44.37%) — (51.96%)
Return on assets (35.06%) — (46.06%)
Return on invested capital 0.00% — 0.00%

Growth

Metric ARCT CUVL Biotechnology median
Revenue growth (TTM) (68.74%) — 6.76%
EPS growth (last fiscal year) 20.00% — 29.88%
Revenue growth, 5-year CAGR 53.78% — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ARCT CUVL Biotechnology median
Debt to equity 0.00 — 0.00
Current ratio 6.68 — 4.97
Net debt to EBITDA 3.15 — 1.01

Dividend

Metric ARCT CUVL Biotechnology median
Dividend yield — 0.56% 0.41%
Payout ratio — — —

Size

Metric ARCT CUVL Biotechnology median
Market cap 298.31m 257.50m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack